You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
|
|---|---|
| Published in |
Journal of Clinical Oncology, July 2014
|
| DOI | 10.1200/jco.2013.54.6911 |
| Pubmed ID | |
| Authors |
Robert J Motzer, Carlos H Barrios, Tae Min Kim, Silvia Falcon, Thomas Cosgriff, W Graydon Harker, Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W Flaig, Ray Page, Sevil Bavbek, J Thaddeus Beck, Poulam Patel, Foon-Yiu Cheung, Sunil Yadav, Edward M Schiff, Xufang Wang, Julie Niolat, Dalila Sellami, Oezlem Anak, Jennifer J Knox |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 20% |
| Spain | 2 | 20% |
| Italy | 1 | 10% |
| United Kingdom | 1 | 10% |
| Unknown | 4 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 70% |
| Practitioners (doctors, other healthcare professionals) | 2 | 20% |
| Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| France | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 216 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 37 | 17% |
| Researcher | 29 | 13% |
| Student > Bachelor | 23 | 11% |
| Student > Ph. D. Student | 19 | 9% |
| Student > Doctoral Student | 19 | 9% |
| Other | 54 | 25% |
| Unknown | 38 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 119 | 54% |
| Nursing and Health Professions | 14 | 6% |
| Agricultural and Biological Sciences | 13 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 8 | 4% |
| Other | 12 | 5% |
| Unknown | 43 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2018.
All research outputs
#2,529,659
of 25,371,288 outputs
Outputs from Journal of Clinical Oncology
#5,967
of 22,043 outputs
Outputs of similar age
#24,592
of 239,672 outputs
Outputs of similar age from Journal of Clinical Oncology
#66
of 229 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,672 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 229 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.